Immunohistochemically, the tumor cells are immunoreactive for cytokeratins and desmin and show strong nuclear expression for WT1 (C terminus) [11] and harbor a distinctive EWSR1-WT1 fusion in the molecular pathology [12]. The gene discussed is WT1; the disease is neoplasm.